Sylvie Bonvalot
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Sylvie Bonvalot has a total of 50 co-authors. Here are the top co-authors by number of shared publications:
Axel Le Cesne
Institut Gustave Roussy
4 shared publicationsCharles Honoré
Department of Surgical Oncology, Gustave Roussy Cancer Center, Villejuif, France
4 shared publicationsPhilippe Terrier
Institut Gustave Roussy
4 shared publications- Olivier Mir
Department of Ambulatory Cancer Care, Gustave Roussy, Villejuif, France
3 shared publications - Alessandro Gronchi
Department of Surgery, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy
2 shared publications Cecile Le Péchoux
Institut Gustave Roussy
2 shared publications
Latest Publications
- 18 August 2015
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 53 (08) , KC131
Strategien und Komplikationen multiviszeraler Resektionen bei retroperitonealen Sarkomen – Ergebnisse der internationalen Arbeitsgruppe Retroperitoneale Sarkome
Einleitung: Die Resektion retroperitonealer Sarkome ist aufgrund der Tumorgröße und intratumoraler Heterogenität eine Herausforderung. Eine R0 Resektion kann nur durch multiviszerales Vorgehen erreicht werden. Die potentielle Morbidität führt oft zu weniger radikaler Verfahren. Ziel unserer Studie war die Analyse chirurgischer Komplikationen in Relation zur Strategie der Behandlung. Material und Methoden: Eingeschlossen wurden 1007 konsekutive Patienten aus 8 Zentren mit potentiell kurativer Resektion eines retroperitonealen Sarkoms zwischen 2002 und 2011. Die Daten wurden prospektiven Datenbanken entnommen und retrospektiv analysiert. Die mediane Nachbeobachtungszeit betrug 58 Monate (Interquartilsabstand 36 – 90 Monate). Ergebnisse: Das mediane Alter betrug 58 Jahre (Interquartilsabsstand 48 – 67 Jahre). Die mediane Tumorgröße betrug 20 cm (Interquartilsabstand 13 – 30 cm). Bei 960/1007 Patienten erfolgte eine R0/R1 Resektion, bei 47/1007 Patienten wurde eine R2 Resektion durchgeführt. Bei 688/1007 Patienten wurde eine multiviszerale Resektion mit Entfernung von zwei oder mehr Organen durchgeführt. 322/1007 Patienten erhielten eine perioperative Strahlentherapie und 183/1007 Patienten eine perioperative Chemotherapie. Bei 199/1007 Patienten traten postoperativ interventionspflichtige Komplikationen auf (>= CTCAE Grad 3). Bei 106/1007 Patienten war eine Re-Operation erforderlich. Die häufigsten postoperativen Komplikationen waren postoperative Blutungen (n = 30), Anastomoseninsuffizienzen (n = 26) und postoperativer Ileus (n = 23). Die 30, 60 und 90 Tage Mortalität betrug jeweils 1,8 (95% CI 1, 2,6), 2,9 (95% CI 1,8, 3,9) and 4,1% (95% CI 2,9, 5,3). Das nach Kaplan-Meier geschätzte 5-Jahresüberleben betrug 67% (95% CI 63, 70). Schlussfolgerung: In dieser multizentrischen Studie zeigte sich eine hohe vollständige Resektionsrate und niedrige postoperative Komplikations- und Mortalitätsrate. Die Anzahl resezierter Organe trug nicht zu einer signifikanten Erhöhung der Morbidität bei.
- 18 August 2015
- Published by Georg Thieme Verlag KG in Zeitschrift für Gastroenterologie
- Vol. 53 (08) , KC131
Strategien und Komplikationen multiviszeraler Resektionen bei retroperitonealen Sarkomen – Ergebnisse der internationalen Arbeitsgruppe Retroperitoneale Sarkome
Einleitung: Die Resektion retroperitonealer Sarkome ist aufgrund der Tumorgröße und intratumoraler Heterogenität eine Herausforderung. Eine R0 Resektion kann nur durch multiviszerales Vorgehen erreicht werden. Die potentielle Morbidität führt oft zu weniger radikaler Verfahren. Ziel unserer Studie war die Analyse chirurgischer Komplikationen in Relation zur Strategie der Behandlung. Material und Methoden: Eingeschlossen wurden 1007 konsekutive Patienten aus 8 Zentren mit potentiell kurativer Resektion eines retroperitonealen Sarkoms zwischen 2002 und 2011. Die Daten wurden prospektiven Datenbanken entnommen und retrospektiv analysiert. Die mediane Nachbeobachtungszeit betrug 58 Monate (Interquartilsabstand 36 – 90 Monate). Ergebnisse: Das mediane Alter betrug 58 Jahre (Interquartilsabsstand 48 – 67 Jahre). Die mediane Tumorgröße betrug 20 cm (Interquartilsabstand 13 – 30 cm). Bei 960/1007 Patienten erfolgte eine R0/R1 Resektion, bei 47/1007 Patienten wurde eine R2 Resektion durchgeführt. Bei 688/1007 Patienten wurde eine multiviszerale Resektion mit Entfernung von zwei oder mehr Organen durchgeführt. 322/1007 Patienten erhielten eine perioperative Strahlentherapie und 183/1007 Patienten eine perioperative Chemotherapie. Bei 199/1007 Patienten traten postoperativ interventionspflichtige Komplikationen auf (>= CTCAE Grad 3). Bei 106/1007 Patienten war eine Re-Operation erforderlich. Die häufigsten postoperativen Komplikationen waren postoperative Blutungen (n = 30), Anastomoseninsuffizienzen (n = 26) und postoperativer Ileus (n = 23). Die 30, 60 und 90 Tage Mortalität betrug jeweils 1,8 (95% CI 1, 2,6), 2,9 (95% CI 1,8, 3,9) and 4,1% (95% CI 2,9, 5,3). Das nach Kaplan-Meier geschätzte 5-Jahresüberleben betrug 67% (95% CI 63, 70). Schlussfolgerung: In dieser multizentrischen Studie zeigte sich eine hohe vollständige Resektionsrate und niedrige postoperative Komplikations- und Mortalitätsrate. Die Anzahl resezierter Organe trug nicht zu einer signifikanten Erhöhung der Morbidität bei.
- 1 April 2015
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 41 (4) , 571-576
Toward a new strategy in desmoid of the breast?
- 1 April 2015
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 41 (4) , 571-576
Toward a new strategy in desmoid of the breast?
- 12 December 2014
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 30 (7) , 993-994
Lessons from an aggressive angiomyxoma unrecognized and treated as rectal prolapse
- 12 December 2014
- Published by Springer Nature in International Journal of Colorectal Disease
- Vol. 30 (7) , 993-994
Lessons from an aggressive angiomyxoma unrecognized and treated as rectal prolapse
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S33-S34
65. A multicenter experience of TNF-αa and melphalan based isolated limb perfusion in patients with locally advanced extremity desmoid tumours
- 1 November 2014
- Published by Elsevier in European Journal of Surgical Oncology
- Vol. 40 (11) , S33-S34
65. A multicenter experience of TNF-αa and melphalan based isolated limb perfusion in patients with locally advanced extremity desmoid tumours
- 10 October 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (5) , 1447-1454
Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection
Purpose To explore patterns of failure and postrelapse outcome of patients with retroperitoneal sarcoma primarily treated by extended resection.
- 10 October 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (5) , 1447-1454
Personalizing the Approach to Retroperitoneal Soft Tissue Sarcoma: Histology-specific Patterns of Failure and Postrelapse Outcome after Primary Extended Resection
Purpose To explore patterns of failure and postrelapse outcome of patients with retroperitoneal sarcoma primarily treated by extended resection.
- 10 October 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (4) , 1073-1079
Abdominal Desmoplastic Small Round Cell Tumor: Multimodal Treatment Combining Chemotherapy, Surgery, and Radiotherapy is the Best Option
With nearly 450 cases reported since 1991, desmoplastic small round cell tumor (DSRCT) is a rare abdominal tumor typically arising in adolescent and young adult white men. With no large series described, the best therapeutic strategy remains unclear. All consecutive patients treated in our tertiary care center between January 1991 and December 2013 for a DSRCT were retrospectively studied. Thirty-eight patients with a median age of 27 years (range 13–57 years) were identified; 71 % were men. At the time of diagnosis, 47.4 % patients had extraperitoneal metastases (EPM): 78 % were located in the liver and 11 % were located in the lungs. Fourteen patients (37 %) were treated exclusively with systemic chemotherapy, with a median survival of 21.1 months. Twenty-three patients underwent surgery, 12 (52 %) experienced complete removal of all macroscopic disease, 5 (21.7 %) received additional intraperitoneal chemotherapy, and 7 (30 %) received postoperative whole abdominopelvic radiotherapy (WAP RT). With a median follow-up of 59.9 months, the median survival was 37.7 months, and the median disease-free survival was 15.5 months. The factors predictive of 3-year overall survival were the absence of EPM, complete surgical resection, postoperative WAP RT, and postoperative chemotherapy. The intraperitoneal chemotherapy had no impact on overall survival. DSRCT is a rare and aggressive disease. In patients without EPM, a multimodal treatment combining systemic chemotherapy, complete macroscopic resection, and postoperative WAP RT could enable prolonged survival. No benefit of surgery was demonstrated for patients with EPM. The value of associated hyperthermic intraperitoneal chemotherapy remains unproven.
- 10 October 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 22 (4) , 1073-1079
Abdominal Desmoplastic Small Round Cell Tumor: Multimodal Treatment Combining Chemotherapy, Surgery, and Radiotherapy is the Best Option
With nearly 450 cases reported since 1991, desmoplastic small round cell tumor (DSRCT) is a rare abdominal tumor typically arising in adolescent and young adult white men. With no large series described, the best therapeutic strategy remains unclear. All consecutive patients treated in our tertiary care center between January 1991 and December 2013 for a DSRCT were retrospectively studied. Thirty-eight patients with a median age of 27 years (range 13–57 years) were identified; 71 % were men. At the time of diagnosis, 47.4 % patients had extraperitoneal metastases (EPM): 78 % were located in the liver and 11 % were located in the lungs. Fourteen patients (37 %) were treated exclusively with systemic chemotherapy, with a median survival of 21.1 months. Twenty-three patients underwent surgery, 12 (52 %) experienced complete removal of all macroscopic disease, 5 (21.7 %) received additional intraperitoneal chemotherapy, and 7 (30 %) received postoperative whole abdominopelvic radiotherapy (WAP RT). With a median follow-up of 59.9 months, the median survival was 37.7 months, and the median disease-free survival was 15.5 months. The factors predictive of 3-year overall survival were the absence of EPM, complete surgical resection, postoperative WAP RT, and postoperative chemotherapy. The intraperitoneal chemotherapy had no impact on overall survival. DSRCT is a rare and aggressive disease. In patients without EPM, a multimodal treatment combining systemic chemotherapy, complete macroscopic resection, and postoperative WAP RT could enable prolonged survival. No benefit of surgery was demonstrated for patients with EPM. The value of associated hyperthermic intraperitoneal chemotherapy remains unproven.
- 9 April 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (7) , 2117-2118
Sporadic Abdominal Wall Desmoid: Is it Time to Change Our First-Line Approach?
- 9 April 2014
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (7) , 2117-2118
Sporadic Abdominal Wall Desmoid: Is it Time to Change Our First-Line Approach?
- Top Cited Papers
- 20 September 2013
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 20 (13) , 4096-4102
Spontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought
Purpose The relevance of the initial observational approach for desmoid tumors (DTs) remains unclear. We investigated a new conservative management treatment for primary abdominal wall DTs.
- 20 September 2013
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 20 (13) , 4096-4102
Top Cited PapersSpontaneous Regression of Primary Abdominal Wall Desmoid Tumors: More Common than Previously Thought
Purpose The relevance of the initial observational approach for desmoid tumors (DTs) remains unclear. We investigated a new conservative management treatment for primary abdominal wall DTs.
- 18 September 2013
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (1) , 269-276
Epithelioid Sarcoma: Need for a Multimodal Approach to Maximize the Chances of Curative Conservative Treatment
This study was designed to evaluate the impact of multimodal management on a series of epithelioid sarcoma (ES) patients treated with curative intent. Data were collected on 69 consecutive patients treated from 1982 to 2012. Univariate and multivariate analyses were performed for tumor control and overall survival (OS). In total, 54 (78 %) patients had localized ES (M0 group). In the M0 group, 85 % of patients received multimodal management (surgery n = 50, radiotherapy n = 37, chemotherapy n = 30). Among 42 patients with limb ES, 9 (21 %) underwent amputation, and isolated limb perfusion (ILP) was required in 17 (40.5 %) to allow conservative management. Among the 45 patients who underwent conservative surgery, flap reconstructions were required in 13 (28.8 %). The median follow-up was 5.7 years. The 5-year actuarial OS rates were 54, 62, and 24 % in the entire group and the M0 and M1 groups, respectively. In the M0 group, the 5-year actuarial distant control, local control (LC), and locoregional control rates were 67, 75, and 66 %, respectively. Prognostic factors for poor OS in the multivariate analysis were tumors that were deep to the fascia (p = 0.04) and grade 3 (p = 0.005). In the univariate analysis, age p = 0.04), the T2 stage (p = 0.04), and mass presentation (p = 0.03) correlated with decreased LC, whereas patients who underwent ILP had a significantly higher LC rate (hazard ratio 3; 95 % confidence interval 0.9–9.4; p = 0.05). Multimodal management including ILP and flap reconstruction is necessary to achieve optimal conservative LC. High rates of metastasis and lymphatic spread require innovative systemic treatments.
- 18 September 2013
- Published by Springer Nature in Annals of Surgical Oncology
- Vol. 21 (1) , 269-276
Epithelioid Sarcoma: Need for a Multimodal Approach to Maximize the Chances of Curative Conservative Treatment
This study was designed to evaluate the impact of multimodal management on a series of epithelioid sarcoma (ES) patients treated with curative intent. Data were collected on 69 consecutive patients treated from 1982 to 2012. Univariate and multivariate analyses were performed for tumor control and overall survival (OS). In total, 54 (78 %) patients had localized ES (M0 group). In the M0 group, 85 % of patients received multimodal management (surgery n = 50, radiotherapy n = 37, chemotherapy n = 30). Among 42 patients with limb ES, 9 (21 %) underwent amputation, and isolated limb perfusion (ILP) was required in 17 (40.5 %) to allow conservative management. Among the 45 patients who underwent conservative surgery, flap reconstructions were required in 13 (28.8 %). The median follow-up was 5.7 years. The 5-year actuarial OS rates were 54, 62, and 24 % in the entire group and the M0 and M1 groups, respectively. In the M0 group, the 5-year actuarial distant control, local control (LC), and locoregional control rates were 67, 75, and 66 %, respectively. Prognostic factors for poor OS in the multivariate analysis were tumors that were deep to the fascia (p = 0.04) and grade 3 (p = 0.005). In the univariate analysis, age p = 0.04), the T2 stage (p = 0.04), and mass presentation (p = 0.03) correlated with decreased LC, whereas patients who underwent ILP had a significantly higher LC rate (hazard ratio 3; 95 % confidence interval 0.9–9.4; p = 0.05). Multimodal management including ILP and flap reconstruction is necessary to achieve optimal conservative LC. High rates of metastasis and lymphatic spread require innovative systemic treatments.